Task: Please answer the following question about the molecule with SMILES OC[C@H]1NC[C@H](O)[C@@H](O)[C@H]1O.
Request: Please describe this drug.
Result: Migalastat is pharmacologic chaperone of alpha-galactosidase the intrahepatic enzyme that is deficient in Fabry disease. Clinical experience with migalastat is limited, but it not been linked to serum enzyme elevations during therapy or to instances of clinically apparent acute liver injury.
Task: Please answer the following question about the molecule with {SMILES__description} {SMILES#}.
{#Description|Question|Request!}: {quest#}
{#Result|Answer|Completion!}: {answ#}
OC[C@H]1NC[C@H](O)[C@@H](O)[C@H]1O
C1[C@@H]([C@H]([C@H]([C@H](N1)CO)O)O)O
(2R,3S,4R,5S)-2-(hydroxymethyl)piperidine-3,4,5-triol
Please describe this drug.
Migalastat is pharmacologic chaperone of alpha-galactosidase the intrahepatic enzyme that is deficient in Fabry disease. Clinical experience with migalastat is limited, but it not been linked to serum enzyme elevations during therapy or to instances of clinically apparent acute liver injury.